Chinese english Germany Japanese Korea

1-((1s,4s)-4-(tert-butyldimethylsilyloxy)cyclohexyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

1-((1s,4s)-4-(tert-butyldimethylsilyloxy)cyclohexyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole Struktur
1257997-17-3
CAS-Nr.
1257997-17-3
Englisch Name:
1-((1s,4s)-4-(tert-butyldimethylsilyloxy)cyclohexyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Synonyma:
1-[trans-4-[(tert-butyldimethylsilyl)oxy]cyclohexyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;1-((1s,4s)-4-(tert-butyldimethylsilyloxy)cyclohexyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;1-((1r,4r)-4-((tert-butyldimethylsilyl)oxy)cyclohexyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;1H-Pyrazole, 1-[trans-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]cyclohexyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CBNumber:
CB82742984
Summenformel:
C21H39BN2O3Si
Molgewicht:
406.44
MOL-Datei:
1257997-17-3.mol
Request For Quotation

1-((1s,4s)-4-(tert-butyldimethylsilyloxy)cyclohexyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole Eigenschaften

Siedepunkt:
466.8±35.0 °C(Predicted)
Dichte
1.03±0.1 g/cm3(Predicted)
pka
3.10±0.19(Predicted)

Sicherheit

1-((1s,4s)-4-(tert-butyldimethylsilyloxy)cyclohexyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole Chemische Eigenschaften,Einsatz,Produktion Methoden

1-((1s,4s)-4-(tert-butyldimethylsilyloxy)cyclohexyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1-((1s,4s)-4-(tert-butyldimethylsilyloxy)cyclohexyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 19)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Chengdu Aslee Biopharmaceuticals, Inc. 		28-85305008
CHINA 964 58
NINGBOBENKANGJS PHARMTECHCO., LTD 		+8615990591583 15990591583
 CHINA 2029 58
Hangzhou MolCore BioPharmatech Co.,Ltd. 		+86-057181025280; +8617767106207
 sales@molcore.com China 49739 58
Aladdin Scientific 		+1-833-552-7181
sales@aladdinsci.com United States 52927 58
Chengdu Aslee Biopharmaceuticals, Inc 028-85305008 02885305008
 2306208234@qq.com China 1004 50
Shanghai YuanQi Biotechnology Co., Ltd. +86-2332782371 +86-18120098618
 sales@adobechem.com China 1250 50
Adobe Chem Co., Ltd. 2332782371
adobechem@qq.com China 7980 58
Aikon International Limited 025-66028182 18112977050
 cfzhang@aikonchem.com China 15820 58
Shanghai Benso Pharmaceutical Technology Co., Ltd. 15088289376
 248775804@qq.com China 4973 58
Ningbo Benkang jishi Pharmaceutical Technology Co., Ltd. 15990591583
 China 5562 58
  • 1-((1s,4s)-4-(tert-butyldimethylsilyloxy)cyclohexyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
  • 1-[trans-4-[(tert-butyldimethylsilyl)oxy]cyclohexyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
  • 1-((1r,4r)-4-((tert-butyldimethylsilyl)oxy)cyclohexyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
  • 1H-Pyrazole, 1-[trans-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]cyclohexyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
  • 1257997-17-3
Copyright 2019 © ChemicalBook. All rights reserved